📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response. (2021)

First Author: Carr DF

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.14407

PubMed Identifier: 32501544

Publication URI: http://europepmc.org/abstract/MED/32501544

Type: Journal Article/Review

Volume: 87

Parent Publication: British journal of clinical pharmacology

Issue: 2

ISSN: 0306-5251